Literature DB >> 17632527

Essential role of stromally induced hedgehog signaling in B-cell malignancies.

Christine Dierks1, Jovana Grbic, Katja Zirlik, Ronak Beigi, Nathan P Englund, Gui-Rong Guo, Hendrik Veelken, Monika Engelhardt, Roland Mertelsmann, Joseph F Kelleher, Peter Schultz, Markus Warmuth.   

Abstract

Interaction of cancer cells with their microenvironment generated by stromal cells is essential for tumor cell survival and influences the localization of tumor growth. Here we demonstrate that hedgehog ligands secreted by bone-marrow, nodal and splenic stromal cells function as survival factors for malignant lymphoma and plasmacytoma cells derived from transgenic Emu-Myc mice or isolated from humans with these malignancies. Hedgehog pathway inhibition in lymphomas induced apoptosis through downregulation of Bcl2, but was independent of p53 or Bmi1 expression. Blockage of hedgehog signaling in vivo inhibited expansion of mouse lymphoma cells in a syngeneic mouse model and reduced tumor mass in mice with fully developed disease. Our data indicate that stromally induced hedgehog signaling may provide an important survival signal for B- and plasma-cell malignancies in vitro and in vivo. Disruption of this interaction by hedgehog pathway inhibition could provide a new strategy in lymphoma and multiple myeloma therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632527     DOI: 10.1038/nm1614

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  139 in total

Review 1.  Targeting Hedgehog--a cancer stem cell pathway.

Authors:  Akil A Merchant; William Matsui
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

2.  Non-cell-autonomous hedgehog signaling promotes murine B lymphopoiesis from hematopoietic progenitors.

Authors:  Christopher L Cooper; Richard R Hardy; Michael Reth; Stephen Desiderio
Journal:  Blood       Date:  2012-04-18       Impact factor: 22.113

3.  Quantitative analysis of cell tracing by in vivo imaging system.

Authors:  Junmeng Zheng; Lijun Xu; Hongmin Zhou; Weina Zhang; Zhonghua Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

Review 4.  The host-tumor interface in B-cell non-Hodgkin lymphoma: a new world to investigate.

Authors:  Nicolas Rachinel; Gilles Salles
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

Review 5.  Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.

Authors:  Wan Zhang; Peng Huang
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

Review 6.  Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.

Authors:  Patricia Pérez-Galán; Martin Dreyling; Adrian Wiestner
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

7.  Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.

Authors:  Osman Cen; Richard Longnecker
Journal:  Mol Cancer Ther       Date:  2011-01-31       Impact factor: 6.261

8.  Maintenance of the BMP4-dependent stress erythropoiesis pathway in the murine spleen requires hedgehog signaling.

Authors:  John M Perry; Omid F Harandi; Prashanth Porayette; Shailaja Hegde; Arun K Kannan; Robert F Paulson
Journal:  Blood       Date:  2008-10-16       Impact factor: 22.113

9.  Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance.

Authors:  Zhongwei Cao; Bi-Sen Ding; Peipei Guo; Sharrell B Lee; Jason M Butler; Stephanie C Casey; Michael Simons; Wayne Tam; Dean W Felsher; Koji Shido; Arash Rafii; Joseph M Scandura; Shahin Rafii
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

10.  The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.

Authors:  Verline Justilien; Michael P Walsh; Syed A Ali; E Aubrey Thompson; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.